Marksans Pharma Limited — Others, 31-03-2025: Cessation

Mr. Seetharama Raju Buddharaju's tenure as Independent Director of Marksans Pharma has concluded as of March 31, 2025. His exit from the Board and various committees was acknowledged by the Board, which expressed gratitude for his contributions over the years. This change may lead to a restructuring of the Board and could impact governance dynamics. Investors may view this as an opportunity for potential fresh perspectives, though it could also present risks associated with a transition in leadership. Overall, it signals a committed approach to evolving the company's oversight.